chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Headache, Nausea, Pain
Clinical narrative: 1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the; nausea; Fever/low grade fever; itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the; chills; aches; headaches; redness (on right wrist, right inner forearm and on left shoulder a few inches away from the; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills) and PAIN (aches) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills), PAIN (aches), HEADACHE (headaches) and ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the). On 10-Feb-2021, the patient experienced SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 10-Feb-2021, NAUSEA (nausea), CHILLS (chills) and PAIN (aches) had resolved, PYREXIA (Fever/low grade fever) outcome was unknown. At the time of the report, PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), HEADACHE (headaches), ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the) and SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the) had not resolved.            No concomitant medications reported by investigator
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Swelling
Clinical narrative: 1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the; nausea; Fever/low grade fever; itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the; chills; aches; headaches; redness (on right wrist, right inner forearm and on left shoulder a few inches away from the; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills) and PAIN (aches) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills), PAIN (aches), HEADACHE (headaches) and ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the). On 10-Feb-2021, the patient experienced SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 10-Feb-2021, NAUSEA (nausea), CHILLS (chills) and PAIN (aches) had resolved, PYREXIA (Fever/low grade fever) outcome was unknown. At the time of the report, PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), HEADACHE (headaches), ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the) and SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the) had not resolved.            No concomitant medications reported by investigator
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: An erratic pulse; Palpitations; Shortness of breath; Flu-like symptom; Felt sleepy; Aches; Dizziness; Chills; Had fatigue; A headache; Lots of nausea; Low grade fever; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom) and SOMNOLENCE (Felt sleepy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ventricular arrhythmia. Concurrent medical conditions included Iodine allergy.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 07-Feb-2021, the patient experienced HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever). On 08-Feb-2021, HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient Take Benadryl on 07Feb2021 and Carvedilol and a low dose of Statins as a Treatment medication.    This case was linked to MOD-2021-044875 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate irregular, Influenza like illness, Nausea, Pain, Palpitations
Clinical narrative: An erratic pulse; Palpitations; Shortness of breath; Flu-like symptom; Felt sleepy; Aches; Dizziness; Chills; Had fatigue; A headache; Lots of nausea; Low grade fever; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom) and SOMNOLENCE (Felt sleepy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ventricular arrhythmia. Concurrent medical conditions included Iodine allergy.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 07-Feb-2021, the patient experienced HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever). On 08-Feb-2021, HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient Take Benadryl on 07Feb2021 and Carvedilol and a low dose of Statins as a Treatment medication.    This case was linked to MOD-2021-044875 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence
Clinical narrative: An erratic pulse; Palpitations; Shortness of breath; Flu-like symptom; Felt sleepy; Aches; Dizziness; Chills; Had fatigue; A headache; Lots of nausea; Low grade fever; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom) and SOMNOLENCE (Felt sleepy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ventricular arrhythmia. Concurrent medical conditions included Iodine allergy.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 07-Feb-2021, the patient experienced HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever). On 08-Feb-2021, HEART RATE IRREGULAR (An erratic pulse), PALPITATIONS (Palpitations), DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Flu-like symptom), SOMNOLENCE (Felt sleepy), PAIN (Aches), DIZZINESS (Dizziness), CHILLS (Chills), FATIGUE (Had fatigue), HEADACHE (A headache), NAUSEA (Lots of nausea) and PYREXIA (Low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient Take Benadryl on 07Feb2021 and Carvedilol and a low dose of Statins as a Treatment medication.    This case was linked to MOD-2021-044875 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: fever axillary temp: 100.1 and temporal temp: 100.6.; muscle pain; leg weakness; This spontaneous case was reported by an other caregiver and describes the occurrence of MYALGIA (muscle pain), MUSCULAR WEAKNESS (leg weakness) and PYREXIA (fever axillary temp: 100.1 and temporal temp: 100.6.) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (muscle pain) and MUSCULAR WEAKNESS (leg weakness). On 11-Feb-2021, the patient experienced PYREXIA (fever axillary temp: 100.1 and temporal temp: 100.6.). At the time of the report, MYALGIA (muscle pain), MUSCULAR WEAKNESS (leg weakness) and PYREXIA (fever axillary temp: 100.1 and temporal temp: 100.6.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, Pyrexia:. In July 2021, SARS-CoV-2 test: positive Positive. On an unknown date, Pyrexia: 100.6 100.6.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided. Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypokinesia, Insomnia, Myalgia, Pain in extremity
Clinical narrative: could not sleep; full long lasting numbness of the right foot/numbness below the knee; could not move; sharp and extreme pain in calf; swollen leg/knee; little soreness at the injection site; pain and soreness in whole arm (injected arm); This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf) and PERIPHERAL SWELLING (swollen leg/knee) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf), PERIPHERAL SWELLING (swollen leg/knee), VACCINATION SITE PAIN (little soreness at the injection site) and MYALGIA (pain and soreness in whole arm (injected arm)). At the time of the report, INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf), PERIPHERAL SWELLING (swollen leg/knee), VACCINATION SITE PAIN (little soreness at the injection site) and MYALGIA (pain and soreness in whole arm (injected arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment details included Heat application.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: could not sleep; full long lasting numbness of the right foot/numbness below the knee; could not move; sharp and extreme pain in calf; swollen leg/knee; little soreness at the injection site; pain and soreness in whole arm (injected arm); This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf) and PERIPHERAL SWELLING (swollen leg/knee) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf), PERIPHERAL SWELLING (swollen leg/knee), VACCINATION SITE PAIN (little soreness at the injection site) and MYALGIA (pain and soreness in whole arm (injected arm)). At the time of the report, INSOMNIA (could not sleep), HYPOAESTHESIA (full long lasting numbness of the right foot/numbness below the knee), HYPOKINESIA (could not move), PAIN IN EXTREMITY (sharp and extreme pain in calf), PERIPHERAL SWELLING (swollen leg/knee), VACCINATION SITE PAIN (little soreness at the injection site) and MYALGIA (pain and soreness in whole arm (injected arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment details included Heat application.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: red circle about 2 inches in diameter on their arm; the area was itchy; it was warm to the touch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle about 2 inches in diameter on their arm), VACCINATION SITE PRURITUS (the area was itchy) and VACCINATION SITE WARMTH (it was warm to the touch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle about 2 inches in diameter on their arm), VACCINATION SITE PRURITUS (the area was itchy) and VACCINATION SITE WARMTH (it was warm to the touch). At the time of the report, VACCINATION SITE ERYTHEMA (red circle about 2 inches in diameter on their arm), VACCINATION SITE PRURITUS (the area was itchy) and VACCINATION SITE WARMTH (it was warm to the touch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication includes blood pressure and cholesterol medicines. Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Lump on her arm; hot; red; itchy; it was like the flu shot; A spontaneous report was received from a healthcare professional concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events it was like the flu shot/influenza like illness, lump/vaccination site lump, red/vaccination site erythema, itchy/vaccination site pruritus, hot/vaccination site warmth.  The patient's medical history was not provided. Concomitant medications reported were calcium carbonate, potassium chloride, dibasic calcium phosphate, magnesium oxide, ascorbic acid , microcrystalline cellulose, dl-alpha tocopheryl acetate, modified corn starch, corn starch, maltodextrin(Centrum Silver), vitamin D3 for unknown indication.  On 29 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 29 Jan 2021, after receiving the vaccine, the patient experienced the events it was like the flu shot. On 1 Feb 2021, three days after receiving the vaccine,  she had a lump on her arm. It was red, hot and itchy. Treatment details included unspecified antihistamine.  Action taken with mRNA-1273 in response to the events was not reported.   On 6 Feb 2021 the outcome of event it was like the flu shot was resolved.  On 8 Feb 2021 the outcome of events lump, red, itchy was resolved.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature increased, Pyrexia
Clinical narrative: Fever 102.7 F; Hip Pain; A spontaneous report was received from a consumer concerning a 85-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events hip pain, fever 102.7 F(Fahrenheit).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 015M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient woke up with the event(s) hip pain, fever 102.7 F.  Treatment details included Tylenol with Hydrocodone Tablet on morning for hip pain. Tthe fever came down quickly.  Action taken with mRNA-1273 in response to the events were not reported.   The outcome of event(s), hip pain, and fever 102.7 F were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Slightly sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Slightly sore arm). At the time of the report, PAIN IN EXTREMITY (Slightly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Same reporter
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus
Clinical narrative: Itchiness; Redness; Sore Arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), ERYTHEMA (Redness) and PAIN IN EXTREMITY (Sore Arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 04-Feb-2021, the patient experienced PRURITUS (Itchiness) and ERYTHEMA (Redness). At the time of the report, PRURITUS (Itchiness) and ERYTHEMA (Redness) outcome was unknown and PAIN IN EXTREMITY (Sore Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     The patient reported that following her first shot of COVID vaccine, she had a sore arm, which went away afterwards (details not provided). Six days later of her vaccine shot, she experienced redness and itchiness in her arm that still persisted. Reportedly, the patient was on cholesterol medication (details not provided). Details regarding treatment medications were not provided. The patient wanted to know, how long her side effects will last.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red rash at the injection site; itching at the injection site; pain at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE RASH (red rash at the injection site) and VACCINATION SITE PAIN (pain at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Lumbago and Cholesterol. Concomitant products included RANITIDINE for Cholesterol, DICLOFENAC and IBUPROFEN for Lumbago.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site). On 10-Feb-2021, the patient experienced VACCINATION SITE RASH (red rash at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE RASH (red rash at the injection site) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was taking an unspecified medicine for cholesterol, along with ranitidine (details not provided). The patient reported that following her first shot of COVID vaccine, she experienced pain at injection site. On 09-Feb-2021, she experienced her arm at the injection site was itchy and the following day, she noticed a red itchy rash at the injection site. Reportedly, she did not receive any treatment for the symptoms, however was curious to know if these symptoms were normal or not.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Fever at the injection site; Itching at the injection site; Hardness at the injection site; injection site swelling; Slight redness that is spreading; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Fever at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (Slight redness that is spreading) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (Fever at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (Slight redness that is spreading). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Vaccination site swelling, Vaccination site erythema, Vaccination site warmth, Vaccination site pruritus and Vaccination site induration, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date for Vaccination site swelling, Vaccination site pruritus, Vaccination site warmth, Vaccination site induration and Vaccination site erythema, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Fever at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE INDURATION (Hardness at the injection site), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (Slight redness that is spreading) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-027298.; Sender's Comments:  MOD21-027298:
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction
Clinical narrative: Delayed injection site reaction; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (Delayed injection site reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE REACTION (Delayed injection site reaction). At the time of the report, INJECTION SITE REACTION (Delayed injection site reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Reactions; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reactions). At the time of the report, ADVERSE REACTION (Reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Details regarding adverse event, concomitant medications and treatment medications were not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation, Myalgia, Rash, Urinary tract disorder
Clinical narrative: constipation; symptoms of urinary issues; rashes; muscle aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CONSTIPATION (constipation), URINARY TRACT DISORDER (symptoms of urinary issues), RASH (rashes) and MYALGIA (muscle aches) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced CONSTIPATION (constipation), URINARY TRACT DISORDER (symptoms of urinary issues), RASH (rashes) and MYALGIA (muscle aches). At the time of the report, CONSTIPATION (constipation), URINARY TRACT DISORDER (symptoms of urinary issues), RASH (rashes) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.      The patient's daughter called and wanted to confirm if the symptoms the patient was experiencing were as a result of the vaccine he received or not. Reportedly, the patient was on high blood pressure and diabetes medications (details not provided). The patient developed rashes and muscle aches after his first shot, that eventually went away. He was also experiencing symptoms of urinary issues and constipation. His daughter also reported that the patient did not have HCP (details not provided). Details regarding treatment medications were also not provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Malaise, Myalgia
Clinical narrative: Fever of 102.4; Not feeling well last night; Felt sore, like he worked out; Arm hurt; Fatigue; Muscle pain; Joint pains; Swollen on injection site; Nauseas; Chills on and off; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue) and MYALGIA (Muscle pain) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sleep apnea. Concurrent medical conditions included Penicillin allergy.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue), MYALGIA (Muscle pain), ARTHRALGIA (Joint pains), VACCINATION SITE SWELLING (Swollen on injection site) and CHILLS (Chills on and off). 10-Feb-2021, the patient experienced NAUSEA (Nauseas). On 11-Feb-2021, the patient experienced PYREXIA (Fever of 102.4). At the time of the report, MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue), MYALGIA (Muscle pain), ARTHRALGIA (Joint pains), VACCINATION SITE SWELLING (Swollen on injection site), NAUSEA (Nauseas), CHILLS (Chills on and off) and PYREXIA (Fever of 102.4) outcome was unknown.            The patient's wife called and reported that the patient was not feeling well in the night, after he received his 2nd dose of COVID-19 vaccine shot. His body temperature was 102.4 degree F on the following day. The patient was not taking any concomitant medications. Details regarding treatment medications were not reported.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia, Vaccination site swelling
Clinical narrative: Fever of 102.4; Not feeling well last night; Felt sore, like he worked out; Arm hurt; Fatigue; Muscle pain; Joint pains; Swollen on injection site; Nauseas; Chills on and off; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue) and MYALGIA (Muscle pain) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sleep apnea. Concurrent medical conditions included Penicillin allergy.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue), MYALGIA (Muscle pain), ARTHRALGIA (Joint pains), VACCINATION SITE SWELLING (Swollen on injection site) and CHILLS (Chills on and off). 10-Feb-2021, the patient experienced NAUSEA (Nauseas). On 11-Feb-2021, the patient experienced PYREXIA (Fever of 102.4). At the time of the report, MALAISE (Not feeling well last night), PAIN (Felt sore, like he worked out), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Fatigue), MYALGIA (Muscle pain), ARTHRALGIA (Joint pains), VACCINATION SITE SWELLING (Swollen on injection site), NAUSEA (Nauseas), CHILLS (Chills on and off) and PYREXIA (Fever of 102.4) outcome was unknown.            The patient's wife called and reported that the patient was not feeling well in the night, after he received his 2nd dose of COVID-19 vaccine shot. His body temperature was 102.4 degree F on the following day. The patient was not taking any concomitant medications. Details regarding treatment medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling lymph node on the neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling lymph node on the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 08-Feb-2021 at 10:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced LYMPHADENOPATHY (swelling lymph node on the neck). At the time of the report, LYMPHADENOPATHY (swelling lymph node on the neck) had not resolved.            No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling lymph node on the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 08-Feb-2021 at 10:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced LYMPHADENOPATHY (swelling lymph node on the neck). At the time of the report, LYMPHADENOPATHY (swelling lymph node on the neck) had not resolved.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Nasal congestion
Clinical narrative: Sleeping problems; head congestion and mild nasal drippage; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Sleeping problems), NASAL CONGESTION (head congestion and mild nasal drippage) and FATIGUE (Fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INSOMNIA (Sleeping problems), NASAL CONGESTION (head congestion and mild nasal drippage) and FATIGUE (Fatigue). At the time of the report, INSOMNIA (Sleeping problems) had resolved and NASAL CONGESTION (head congestion and mild nasal drippage) and FATIGUE (Fatigue) outcome was unknown. Not Provided          No concomitant medications or treatment details were reported.  Action taken with mRNA-1273 vaccine with the events was not applicable  Patient reported that it was a chronic problem, although the head congestion was more severe than normal, and the nasal drippage couldn't have been related to the vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Reporter's causality for the events were updated. Severity of the event (head congestion and mild nasal drippage) was updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for covid; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for covid) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for covid). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for COVID-19, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for covid) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient wanted to confirm if it is recommended to take the second dose of vaccine or not.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lethargy, Neck pain, Oropharyngeal pain
Clinical narrative: Sore Left Arm; Sore throat; Sore gland left side of her neck; Lethargy; Joint pain; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm), OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy) and ARTHRALGIA (Joint pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included IgG decreased. Concomitant products included IMMUNOGLOBULIN HUMAN NORMAL (CUVITRU) for IgG decreased.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm), OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy), ARTHRALGIA (Joint pain) and HEADACHE (Headache). On 16-Jan-2021, HEADACHE (Headache) had resolved. On 22-Jan-2021, PAIN IN EXTREMITY (Sore Left Arm) had resolved. On 29-Jan-2021, OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy) and ARTHRALGIA (Joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that she was diagnosed with COVID-19 in Mar-2020 (date unspecified) and did not do the test again as she was out of town, however after she recovered from COVID-19, her COVID Antibody test came out to be negative. She also reported that het second dose of Covid-19 vaccine was scheduled on 15-Feb-2021. Details regarding treatment medications were not reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Left Arm; Sore throat; Sore gland left side of her neck; Lethargy; Joint pain; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm), OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy) and ARTHRALGIA (Joint pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included IgG decreased. Concomitant products included IMMUNOGLOBULIN HUMAN NORMAL (CUVITRU) for IgG decreased.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm), OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy), ARTHRALGIA (Joint pain) and HEADACHE (Headache). On 16-Jan-2021, HEADACHE (Headache) had resolved. On 22-Jan-2021, PAIN IN EXTREMITY (Sore Left Arm) had resolved. On 29-Jan-2021, OROPHARYNGEAL PAIN (Sore throat), NECK PAIN (Sore gland left side of her neck), LETHARGY (Lethargy) and ARTHRALGIA (Joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that she was diagnosed with COVID-19 in Mar-2020 (date unspecified) and did not do the test again as she was out of town, however after she recovered from COVID-19, her COVID Antibody test came out to be negative. She also reported that het second dose of Covid-19 vaccine was scheduled on 15-Feb-2021. Details regarding treatment medications were not reported.